atropine should generally not be interrupted during procedures unless there is a specific physician order.
Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
CCU, OR, PACU, CCL, ED
PCU
2N (Tele)
1N (Tele), 3N (Tele)
Med/Surg (1N w/o Tele, 3N w/o Tele, 4N, 5N)
BirthPlace
SNF
ICS
OPS
atropine IV Key: designated staff
Y
Y
Y
N
Y 1N only for side effects of chemo
N
N
Y only for side effects of chemo
N
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
atropine
excludes ophthalmic
Criteria 1: Potentially inappropriate medication use in older adults. (Table 2)
Drug(s)
GI antispasmodics with strong anticholinergic activity
Rationale
Highly anticholinergic, uncertain effectiveness.
Recommendation
Avoid
Quality of evidence: Moderate, Strength of Recommendation: Strong
Criteria 2: Potentially inappropriate medication use in older adults due to drug–disease or drug–syndrome interactions that may exacerbate the disease or syndrome. (Table 3)
Drug(s) ⇆ disease or syndrome
anticholinergics ⇄ Delirium
Rationale
Avoid in older adults with or at high risk of delirium because of the potential of inducing or worsening delirium.
Recommendation
Avoid
Quality of evidence: Moderate, Strength of Recommendation: Strong
Drug(s) ⇆ disease or syndrome
anticholinergics ⇄ Dementia or cognitive impairment
Rationale
Avoid because of adverse CNS effects. If used, periodic deprescribing attempts should be considered to assess ongoing need and/or the lowest effective dose.
Recommendation
Avoid
Quality of evidence: Moderate, Strength of Recommendation: Strong
Drug(s) ⇆ disease or syndrome
anticholinergics ⇄ History of falls or fractures
Rationale
May cause ataxia, impaired psychomotor function, syncope, or additional falls. If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures. (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, Nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.
Recommendation
Avoid unless safer alternatives are not available.
Quality of evidence: High, Strength of Recommendation: Strong
(KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
IV Key: designated staff
1N only for side effects of chemo
only for side effects of chemo